TNF and metabolic disease: Numerous CKs, such as tumor necrosis factor alpha (TNF-α), IL (interleukin)-6, CRP, and IL-1β, are studied in the interplay between metabolic disease, inflammation, and carcinogenesis, but mediators of innate immunity, namely inflammasomes, are also regarded with increasing interest [6,7,8,9].